CANCER Care in COVID-19 ERA: A Prospective Survey to Study the Preferences and Perspectives of Patients with Hematological Malignancies in a Tertiary Cancer Care Setting in India
Authors:
- Surabhi BhatSBSurabhi Bhat
- Avinash BondaABAvinash Bonda
- Manju SengarMSManju Sengar
- Jayashree ThoratJTJayashree Thorat
- Bhausaheb BagalBBBhausaheb Bagal
- Lingaraj NayakLNLingaraj Nayak
- Jayita DeodharJDJayita Deodhar
- Karthik RengarajKRKarthik Rengaraj
- Neha SharmaNSNeha Sharma
- Sadhana KannanSKSadhana Kannan
- Hemanth MuthuluriHMHemanth Muthuluri
- Smruti MokalSMSmruti Mokal
- 23 March 2024
- journal article
- letter
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 40 (4) , 725-727
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- The Risk and Prognosis of COVID-19 Infection in Cancer PatientsHematology/Oncology and Stem Cell Therapy, 2022
- Cancer Management in India during Covid-19New England Journal of Medicine, 2020
- Cancer guidelines during the COVID-19 pandemicThe Lancet Oncology, 2020
- Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.Journal of Clinical Oncology, 1998